Musk pushes debunked Dominion voting conspiracy theory at first Pennsylvania appearance
The billionaire CEO of Tesla and SpaceX and owner of X has ramped up his support of his conservative super PAC and Trump.
Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
Merck is discussing the study data with regulators worldwide, with a goal of making the treatment available for infants as early as the 2025 to 2026 RSV season.
Nvidia stock rises to new record, exceeding June high as AI trade is rekindled
Shares of Nvidia rose more than 3% on Thursday, briefly tapping a new intraday high of $140.89. It bested a previous record of $140.76, set June 20.
Nearly 2 in 5 cardholders have maxed out a credit card or come close, report finds
Higher prices and higher interest rates have caused many Americans to use more of their available credit. Gen X is particularly stretched.
Unity’s new CEO pitches ‘fundamentally different company’ after rough year
Unity CEO Matt Bromberg, who joined in May, is overseeing his first big product launch since taking over the gaming software company.
Harris distances herself from Biden, bashes Trump in tense Fox News interview
Democratic presidential nominee Kamala Harris bashed Donald Trump in a tense interview with Fox News anchor Bret Baier while distancing herself from Joe Biden.
Lucid stock tumbles following public offering to raise $1.67 billion
Lucid intends to use the proceeds “for general corporate purposes, which may include, among other things, capital expenditures and working capital.”
RTX subsidiary Raytheon to pay more than $950 million to settle foreign bribery, export control fraud probes
The huge legal settlement by Raytheon related to bribery in Qatar, and to defrauding the Pentagon in regard to the Patriot Missile systems.
Is swing state business in better shape than it was four years ago? Here’s what the data says
Was the Biden or Trump administration better for the business climate in swing states? Here’s what the data from CNBC’s annual Top States study says.
Novavax says FDA put hold on combination Covid-flu shot and influenza vaccine; shares plunge
The so-called clinical hold is due to a single report of nerve damage in a patient who received the combination shot in a phase two trial.
